Harwood Feffer LLP Announces Investigation of SRS Labs, Inc.

NEW YORK, April 17, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of SRS Labs, Inc. ("SRS Labs" or the "Company") (NASDAQ: SRSL) concerning the proposed acquisition of the Company by DTS, Inc. ("DTS") in a transaction valued at approximately $148 million. 

On April 17, 2012, it was announced that SRS Labs and DTS have entered into a definitive agreement pursuant to which DTS will acquire SRS Labs.  Under the agreement, SRS Labs shareholders will receive a combination of cash and stock valued at approximately $9.50 per share held.  At least one analyst has set a target price for SRS Labs stock of $10.00 per share.

Our investigation concerns whether the SRS Labs board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders. 

If you own SRS Labs shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin Sachs-Michaels
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers:
(877) 935-7400
(212) 935-7400
Email:  bsachsmichaels@hfesq.com
Website:  http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP